FABP4 and metabolic disease: That both endogenous and exogenous H2S promotes FABP4/aP2 expression supports a regulatory role for this gas in regulating adipocyte differentiation and raises the possibility that H2S donors may be of interest in the treatment of a range of metabolic diseases.